Please note that the online, video portions of this report require the most recent version of Adobe Flash Player, which can be obtained as a free download by clicking here.

Accreditation Information: This multi-media conference report is an accredited self-assessment program (Section 3) as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Geriatrics Society (15 hours). Members of the College of Family Physicians of Canada may claim Mainpro-M2 credits for this unaccredited educational program.

The views, opinions, and information contained in this multi-media conference report are those of the authors and do not necessarily reflect the views and opinions of Amgen Canada Inc., and Solvay Pharma Inc. This report was made possible by unrestricted educational grants from Amgen Canada Inc., and Solvay Pharma Inc.

Improving the Lives of Your Aging Male Patients: Considering Whether Testosterone Plays a Meaningful Role

Organized by the Canadian Society for the Study of the Aging Male (CSSAM)

Chair: David Greenberg, BA, MD, Co-chair of Membership Committee, Canadian Society for the Study of the Aging Male, Toronto, ON; Member Of Executive, Department of Family & Community Medicine, St. Joseph's Health Centre, Toronto, ON.

The Prevalence of Hypogonadism among Men who Have Type 2 Diabetes and/or the Metabolic Syndrome—Is it Clinically Relevant?
Speaker: Jeremy Gilbert, MD, FRCPC, Endocrinology and Metabolism, Sunnybrook Health Sciences Centre, Toronto, ON.

Discussing the Association between Cardiovascular Risk and Hypogonadism
Speaker: Juan Carlos Monge, MD, FRCPC, FACC, Associate Professor of Medicine, University of Toronto; Division of Cardiology, St. Michael's Hospital, Toronto, ON.

Testosterone and the Prostate
Speaker: Gerald Brock, MD, FRCSC, Professor, Department of Surgery, Division of Urology, University of Western Ontario, London, ON.
Sponsored by an unrestricted educational grant from Solvay Pharma Inc.

 

The Role of RANK/RANKL/OPG Pathway in Bone Loss—New Insights

Introduction
Chair/Speaker: Angela Juby, MBChB, LRCP, LRCS, LRCPS, Associate Professor, Division of Geriatrics, Department of Medicine, University of Alberta, Edmonton, AB.

Bone Biology and the Role of RANK/RANKL/OPG Pathway
Speaker: Robert G. Josse, MD, Division of Endocrinology & Metabolism, St. Michael's Hospital; Professor of Medicine, University of Toronto, Toronto, ON.

Targeting RANK Ligand Increases Bone Mineral Density in Postmenopausal Women: Results from Phase 3 Trials
Speaker: Alexandra Papaioannou, MD, MSc, FRCPC, Professor, Department of Medicine Director, Division of Geriatric Medicine, McMaster University, Geriatrician, Hamilton Health Sciences Centre, Hamilton, ON.
Sponsored by an unrestricted educational grant from Amgen Canada Inc.